Anyone else think the strategy is pretty poor, we are in a covid...

Anyone else think the strategy is pretty poor, we are in a covid world where beds are no longer available for surgeries but they have a huge sales team effort that is very expensive trying to sell a product that hospitals cannot use in volume at the moment, One would have thought that pausing or significantly reducing the sales team till hospitals can actually use the product may have been far more cost effective. Instead they just burn cash for no real gain. For the number of years it has been around one has to say they have achieved surprising little traction in the market, which begs the question whether there actually is enough of a market for the product for the business to actually survive in the longer term.